Neutrophil-To-Lymphocyte Ratio As A Potential Prognostic Factor Of Disease-Free Survival In High-Risk Renal Cell Carcinoma: Analysis Of The S-Trac Trial.
JOURNAL OF CLINICAL ONCOLOGY(2018)
Abstract
4562Background: Sunitinib significantly improved disease-free survival (DFS) vs placebo (PBO) in patients (pts) with loco-regional renal cell carcinoma (RCC) at high risk of recurrence post nephrec...
MoreTranslated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined